Syed Ahmar Shah

Dr. Syed Ahmar Shah


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 June 2021 in Nature Medicine
Verified
Journal Article
Open access
PDF file
CSC. R. Simpson
C. R. Simpson
TSTing Shi
Ting Shi
EVE. Vasileiou
E. Vasileiou
SKS. V. Katikireddi
S. V. Katikireddi
SKS. Kerr
S. Kerr
ASA. Sheikh
A. Sheikh
Reports of ChAdOx1 vaccine–associated thrombocytopenia and vascular adverse events have led to some countries restricting its use. Using a national prospective cohort, we estimated associations between exposure to first-dose ChAdOx1 or BNT162b2 vaccination and hematological and vascular adverse events using a nested incident-matched case-control study and a confirmatory self-controlled case series (SCCS) analysis. An association was found between ChAdOx1 vaccination and idiopathic thrombocytopenic purpura (ITP) (0–27 d after vaccination; adjusted rate ratio (aRR) = 5.77, 95% confidence interval (CI), 2.41–13.83), with an estimated incidence of 1.13 (0.62–1.63) cases per 100,000 doses. An SCCS analysis confirmed that this was unlikely due to bias (RR = 1.98 (1.29–3.02)). There was also an increased risk for arterial thromboembolic events (aRR = 1.22, 1.12–1.34) 0–27 d after vaccination, with an SCCS RR of 0.97 (0.93–1.02). For hemorrhagic events 0–27 d after vaccination, the aRR was 1.48 (1.12–1.96), with an SCCS RR of 0.95 (0.82–1.11). A first dose of ChAdOx1 was found to be associated with small increased risks of ITP, with suggestive evidence of an increased risk of arterial thromboembolic and hemorrhagic events. The attenuation of effect found in the SCCS analysis means that there is the potential for overestimation of the reported results, which might indicate the presence of some residual confounding or confounding by indication. Public health authorities should inform their jurisdictions of these relatively small increased risks associated with ChAdOx1. No positive associations were seen between BNT162b2 and thrombocytopenic, thromboembolic and hemorrhagic events.

22 June 2020 in Sensors
Verified
Journal Article
Open access
PDF file
Lazzaro di BiaseLazzaro di Biase
Lazzaro di Biase
ASAlessandro Di Santo
Alessandro Di Santo
MCMaria Letizia Caminiti
Maria Letizia Caminiti
ALAlfredo De Liso
Alfredo De Liso
SSSyed Ahmar Shah
Syed Ahmar Shah
VLVincenzo Di Lazzaro
Vincenzo Di Lazzaro
The aim of this review is to summarize that most relevant technologies used to evaluate gait features and the associated algorithms that have shown promise to aid diagnosis and symptom monitoring in Parkinson’s disease (PD) patients. We searched PubMed for studies published between 1 January 2005, and 30 August 2019 on gait analysis in PD. We selected studies that have either used technologies to distinguish PD patients from healthy subjects or stratified PD patients according to motor status or disease stages. Only those studies that reported at least 80% sensitivity and specificity were included. Gait analysis algorithms used for diagnosis showed a balanced accuracy range of 83.5–100%, sensitivity of 83.3–100% and specificity of 82–100%. For motor status discrimination the gait analysis algorithms showed a balanced accuracy range of 90.8–100%, sensitivity of 92.5–100% and specificity of 88–100%. Despite a large number of studies on the topic of objective gait analysis in PD, only a limited number of studies reported algorithms that were accurate enough deemed to be useful for diagnosis and symptoms monitoring. In addition, none of the reported algorithms and technologies has been validated in large scale, independent studies.

7 March 2017 in Journal of Medical Internet Research
Verified
Journal Article
Open access
SSSyed Ahmar Shah
Syed Ahmar Shah
CVCarmelo Velardo
Carmelo Velardo
AFAndrew Farmer
Andrew Farmer
LTLionel Tarassenko
Lionel Tarassenko
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet

3 May 2017 in Journal of Medical Internet Research
Verified
Journal Article
Open access
AFAndrew Farmer
Andrew Farmer
VWVeronika Williams
Veronika Williams
CVCarmelo Velardo
Carmelo Velardo
SSSyed Ahmar Shah
Syed Ahmar Shah
LYLy-Mee Yu
Ly-Mee Yu
LTLionel Tarassenko
Lionel Tarassenko
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet

27 April 2017 in Brain
Verified
Journal Article
Open access
PDF file
Lazzaro di BiaseLazzaro di Biase
Lazzaro di Biase
JBJohn-Stuart Brittain
John-Stuart Brittain
SSSyed Ahmar Shah
Syed Ahmar Shah
DPDavid J. Pedrosa
David J. Pedrosa
HCHayriye Cagnan
Hayriye Cagnan
PBPeter Brown
Peter Brown
See Vidailhet et al. (doi: 10.1093/brain/awx140 ) for a scientific commentary on this article. Misdiagnosis among tremor syndromes is common, and can impact on both clinical care and research. To date no validated neurophysiological technique is available that has proven to have good classification performance, and the diagnostic gold standard is the clinical evaluation made by a movement disorders expert. We present a robust new neurophysiological measure, the tremor stability index, which can discriminate Parkinson’s disease tremor and essential tremor with high diagnostic accuracy. The tremor stability index is derived from kinematic measurements of tremulous activity. It was assessed in a test cohort comprising 16 rest tremor recordings in tremor-dominant Parkinson’s disease and 20 postural tremor recordings in essential tremor, and validated on a second, independent cohort comprising a further 55 tremulous Parkinson’s disease and essential tremor recordings. Clinical diagnosis was used as gold standard. One hundred seconds of tremor recording were selected for analysis in each patient. The classification accuracy of the new index was assessed by binary logistic regression and by receiver operating characteristic analysis. The diagnostic performance was examined by calculating the sensitivity, specificity, accuracy, likelihood ratio positive, likelihood ratio negative, area under the receiver operating characteristic curve, and by cross-validation. Tremor stability index with a cut-off of 1.05 gave good classification performance for Parkinson’s disease tremor and essential tremor, in both test and validation datasets. Tremor stability index maximum sensitivity, specificity and accuracy were 95%, 95% and 92%, respectively. Receiver operating characteristic analysis showed an area under the curve of 0.916 (95% confidence interval 0.797–1.000) for the test dataset and a value of 0.855 (95% confidence interval 0.754–0.957) for the validation dataset. Classification accuracy proved independent of recording device and posture. The tremor stability index can aid in the differential diagnosis of the two most common tremor types. It has a high diagnostic accuracy, can be derived from short, cheap, widely available and non-invasive tremor recordings, and is independent of operator or postural context in its interpretation.

20 February 2017 in BMC Medical Informatics and Decision Making
Verified
Journal Article
Open access
PDF file
OTon behalf of the EDGE COPD Team
on behalf of the EDGE COPD Team
CVCarmelo Velardo
Carmelo Velardo
SSSyed Ahmar Shah
Syed Ahmar Shah
OGOliver Gibson
Oliver Gibson
GCGari D. Clifford
Gari D. Clifford
LTLionel Tarassenko
Lionel Tarassenko
Recent telehealth studies have demonstrated minor impact on patients affected by long-term conditions. The use of technology does not guarantee the compliance required for sustained collection of high-quality symptom and physiological data. Remote monitoring alone is not sufficient for successful disease management. A patient-centred design approach is needed in order to allow the personalisation of interventions and encourage the completion of daily self-management tasks. A digital health system was designed to support patients suffering from chronic obstructive pulmonary disease in self-managing their condition. The system includes a mobile application running on a consumer tablet personal computer and a secure backend server accessible to the health professionals in charge of patient management. The patient daily routine included the completion of an adaptive, electronic symptom diary on the tablet, and the measurement of oxygen saturation via a wireless pulse oximeter. The design of the system was based on a patient-centred design approach, informed by patient workshops. One hundred and ten patients in the intervention arm of a randomised controlled trial were subsequently given the tablet computer and pulse oximeter for a 12-month period. Patients were encouraged, but not mandated, to use the digital health system daily. The average used was 6.0 times a week by all those who participated in the full trial. Three months after enrolment, patients were able to complete their symptom diary and oxygen saturation measurement in less than 1 m 40s (96% of symptom diaries). Custom algorithms, based on the self-monitoring data collected during the first 50 days of use, were developed to personalise alert thresholds. Strategies and tools aimed at refining a digital health intervention require iterative use to enable convergence on an optimal, usable design. ‘Continuous improvement’ allowed feedback from users to have an immediate impact on the design of the system (e.g., collection of quality data), resulting in high compliance with self-monitoring over a prolonged period of time (12-month). Health professionals were prompted by prioritisation algorithms to review patient data, which led to their regular use of the remote monitoring website throughout the trial. Trial registration: ISRCTN40367841 . Registered 17/10/2012.